Feiyi Lu
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
OSCAR functions as a collagen I receptor to suppress hippo signaling and reprogram lipid metabolism in clear-cell renal cell carcinoma.
Journal: Cell death & disease
Published: November 11, 2025
UBL3 governs VEGFR inhibitor resistance by activating NOTCH signaling in renal cell carcinoma.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: September 09, 2025
Emerging roles of metabolic biomarkers in renal cell carcinoma: from molecular mechanisms to clinical implications.
Journal: Frontiers in cell and developmental biology
Published: July 11, 2025
Targeting MMA-induced USP36 methylmalonylation to suppress macrophage polarization and tumor progression in clear-cell renal cell carcinoma.
Journal: Cell death and differentiation
Published: March 12, 2025
Publisher Correction: N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1/IQGAP2/AKT signaling pathway.
Journal: Cell death & disease
Published: August 29, 2024
N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1/IQGAP2/AKT signaling pathway.
Journal: Cell death & disease
Published: March 20, 2024
Hsa_circ_0086414/transducer of ERBB2 (TOB2) axis-driven lipid elimination and tumor suppression in clear cell renal cell cancer via perilipin 3.
Journal: International journal of biological macromolecules
Published: September 04, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026